Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
December 04, 2018 15:50 ET
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri
October 26, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
October 22, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...
Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt
October 10, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos, Inc. a pharmaceutical company researching and developing minimally invasive treatments to combat cancer in humans...
Vivos Inc Signs Memorandum of Understanding with Private Veterinary Hospital as Pilot Clinic for Commercial IsoPet® Therapy
October 02, 2018 07:00 ET
|
Vivos Inc.
Richland, WA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) selected its first clinic for commercial sales of IsoPet Vivos Inc., a pharmaceutical company in the process of researching and...
First Successful Treatment of Canine Sarcoma using IsoPet® to be Presented at Veterinary Cancer Society Conference
September 26, 2018 07:00 ET
|
Vivos Inc.
Richland, WA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC PINK: RDGL) first therapy to canine treat soft tissue sarcoma is successful Vivos Inc, a pharmaceutical company in the process of...
Amending and Replacing the Initial Press Release on George Sharp; Disregard the first release:
September 25, 2018 14:15 ET
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated
September 25, 2018 11:12 ET
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt
September 24, 2018 07:00 ET
|
Vivos Inc.
Richland WA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos’ secured convertible debt have agreed to a ten...
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Create a Debt Free Company
September 21, 2018 17:08 ET
|
Vivos Inc.
Richland WA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos convertible debt have agreed to a 10 day standstill,...